Furthermore, given that loss of FBW7 activity is associated with acquired chemoresistance [57], altered DNA repair activity in FBW7-deficient cancers may contribute to increased tolerance to the toxicity of DNA-damaging chemotherapeutic agents during chemotherapy. The gene discussed is FBXW7; the disease is cancer.